![Adam Levy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 55 437 $ in data 30/09/2026
Mr. Adam S.
Levy is a Chief Financial Officer at Mineralys Therapeutics, Inc. He is on the Board of Directors at Praxis Bioresearch LLC.
Mr. Levy was previously employed as a Chief Business Officer by Vical, Inc., a Chief Business Officer by Brickell Subsidiary, Inc., a Chief Business Officer by Fresh Tracks Therapeutics, Inc., a Chief Business Officer by Miragen Therapeutics, Inc., a Senior Vice President by Merrill Lynch, Pierce, Fenner & Smith, Inc., a Vice President-Healthcare Investment Banking by Wedbush Securities, Inc., and a Chief Financial Officer by Sanifit Therapeutics SA. He received his undergraduate degree from Cornell University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 25/03/2026 | 2.206 ( 0% ) | 55 437 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/03/2022 |
Praxis Bioresearch LLC
 Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Direttore/Membro del Consiglio | 19/09/2023 |
| Società | Posizione | Fine |
|---|---|---|
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Direttore Finanziario/CFO | 01/01/2022 |
Brickell Subsidiary, Inc.
 Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Corporate Officer/Principal | 01/01/2020 |
| VIRIDIAN THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | - |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/05/2016 |
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Corporate Officer/Principal | 01/04/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Fresh Tracks Therapeutics, Inc.
 Fresh Tracks Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops and manufactures prescription therapeutics products for treatment of autoimmune, inflammatory and debilitating diseases | Health Technology |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Health Technology |
Mineralys Therapeutics, Inc.
 Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
